Document Detail

Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
MedLine Citation:
PMID:  21307037     Owner:  NLM     Status:  Publisher    
Aims We sought to determine the effectiveness of early routine percutaneous coronary intervention (PCI) post-fibrinolysis for ST-elevation myocardial infarction (STEMI) in relation to baseline risk status. Methods and results In this post hoc subgroup analysis of Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI), we stratified 1059 STEMI patients receiving tenecteplase into low-intermediate [Global Registry of Acute Coronary Events (GRACE) risk score <155; n = 889] vs. high-risk (GRACE risk score ≥155; n = 170) groups, based on the GRACE risk score for in-hospital mortality. There was a significant interaction between treatment assignment and risk status for the composite endpoint of death/re-MI at 30 days (P for interaction <0.001). Compared with the standard treatment, pharmacoinvasive therapy (early routine PCI) was associated with a lower rate of death/re-MI at 30 days in the low-intermediate risk stratum (8.1 vs. 2.9%, P < 0.001), but a higher rate of death/re-MI in the high-risk group (13.8 vs. 27.8%, P = 0.025). We found similar heterogeneity in the treatment effects on 30-day mortality and death/re-MI at 1 year (P for interaction =0.008 and 0.001, respectively), when the GRACE risk score was analysed as a continuous variable (P for interaction <0.001) and when patients were stratified by the Thrombolysis In Myocardial Infarction (TIMI) risk score (P for interaction = 0.001). Conclusion We observed a strong heterogeneity in the treatment effects of a pharmacoinvasive strategy after fibrinolysis for STEMI, which is associated with improved outcomes only among patients with a low-intermediate GRACE risk score. Conversely, the early invasive strategy is associated with worse outcomes in high-risk patients. These novel findings should be considered exploratory only and require confirmation in other trials and meta-analyses. Clinical Trial Registration Information: number, NCT00164190.
Andrew T Yan; Raymond T Yan; Warren J Cantor; Bjug Borgundvaag; Eric A Cohen; David H Fitchett; Vladimir Dzavik; John Ducas; Mary Tan; Amparo Casanova; Shaun G Goodman;
Related Documents :
6400007 - Infarct size as a determinant of acute and long-term prognosis.
21352967 - Anterior myocardial infarction with dynamic left ventricular outflow tract obstruction.
9581857 - Assessment of left ventricular function using serum cardiac troponin i measurements fol...
24531537 - Autophagic program is regulated by mir-325.
24015037 - Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimen...
12726797 - The relationship between structure and function: why does reshaping the left ventricle ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-8
Journal Detail:
Title:  European heart journal     Volume:  -     ISSN:  1522-9645     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, Toronto, Ontario, Canada, M5B 1W8.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interve...
Next Document:  Pollen tube growth and guidance: roles of small, secreted proteins.